Merck & Co., Inc. (MRK)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter Merck & Co., Inc. has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
EPS (diluted)
$-0.54
Est. $-0.27 · -99.6%
Revenue
$16.61B
Est. $16.37B · +1.5%
Net income
$-1.33B
As filed
EPS YoY
-130.7%
vs quarter ended 2025-06-30
Revenue YoY
+5.1%
vs quarter ended 2025-06-30
Next report
Oct 29, 2026
Scheduled · est. EPS $2.22
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$1.25
2025-09-30 through 2026-06-30
TTM revenue
$66.57B
2025-09-30 through 2026-06-30
Filed quarters
40
On record here
EPS at or above estimate (4Q)
0%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-08-07 | $-0.54 | $16.61B | -130.7% | +5.1% | $-0.27 | -99.6% |
| 2026-03-31Q1 FY2026 | 2026-05-04 | $-1.72 | $16.29B | -185.6% | +4.9% | $-0.41 | -319.5% |
| 2025-12-31Q4 FY2025 | 2026-02-24 | $1.19 | $16.40B | -20.1% | +5.0% | $2.01 | -40.8% |
| 2025-09-30Q3 FY2025 | 2025-11-05 | $2.32 | $17.28B | +87.1% | +3.7% | $2.36 | -1.7% |
| 2025-06-30Q2 FY2025 | 2025-08-05 | $1.76 | $15.81B | -17.8% | -1.9% | $2.03 | -13.3% |
| 2025-03-31Q1 FY2025 | 2025-05-02 | $2.01 | $15.53B | +7.5% | -1.6% | $2.13 | -5.6% |
| 2024-12-31Q4 FY2024 | 2025-02-25 | $1.49 | $15.62B | +410.4% | +6.8% | $1.85 | -19.5% |
| 2024-09-30Q3 FY2024 | 2024-11-06 | $1.24 | $16.66B | -33.3% | +4.4% | $1.50 | -17.3% |
| 2024-06-30Q2 FY2024 | 2024-08-05 | $2.14 | $16.11B | +191.1% | +7.2% | $2.15 | -0.5% |
| 2024-03-31Q1 FY2024 | 2024-05-03 | $1.87 | $15.78B | +68.5% | +8.9% | $1.88 | -0.5% |
| 2023-12-31Q4 FY2023 | 2024-02-26 | $-0.48 | $14.63B | -140.7% | +5.8% | $-0.09 | -433.3% |
| 2023-09-30Q3 FY2023 | 2023-11-03 | $1.86 | $15.96B | +45.3% | +6.7% | $1.95 | -4.6% |
| 2023-06-30Q2 FY2023 | 2023-08-07 | $-2.35 | $15.04B | -251.6% | +3.0% | $-2.17 | -8.3% |
| 2023-03-31Q1 FY2023 | 2023-05-05 | $1.11 | $14.49B | -34.7% | -8.9% | $1.32 | -15.9% |
| 2022-12-31Q4 FY2022 | 2023-02-24 | $1.18 | $13.83B | -20.3% | +2.3% | $1.56 | -24.4% |
| 2022-09-30Q3 FY2022 | 2022-11-03 | $1.28 | $14.96B | -28.9% | +13.7% | $1.67 | -23.4% |
| 2022-06-30Q2 FY2022 | 2022-08-05 | $1.55 | $14.59B | +154.1% | +28.0% | $1.70 | -8.8% |
| 2022-03-31Q1 FY2022 | 2022-05-05 | $1.70 | $15.90B | +36.0% | +49.6% | $1.83 | -7.1% |
| 2021-12-31Q4 FY2021 | 2022-02-25 | $1.48 | $13.52B | +294.7% | +23.5% | — | — |
| 2021-09-30Q3 FY2021 | 2021-11-05 | $1.80 | $13.15B | +55.2% | +20.4% | — | — |
| 2021-06-30Q2 FY2021 | 2021-08-09 | $0.61 | $11.40B | -48.3% | +21.9% | — | — |
| 2021-03-31Q1 FY2021 | 2021-05-05 | $1.25 | $10.63B | +4.2% | -11.9% | — | — |
| 2020-12-31Q4 FY2020 | 2021-02-25 | $-0.76 | $10.95B | -172.4% | +163.9% | — | — |
| 2020-09-30Q3 FY2020 | 2020-11-05 | $1.16 | $10.93B | +63.4% | -11.8% | — | — |
| 2020-06-30Q2 FY2020 | 2020-08-05 | $1.18 | $9.35B | +20.4% | -20.5% | — | — |
| 2020-03-31Q1 FY2020 | 2020-05-06 | $1.20 | $12.06B | +12.1% | +11.5% | — | — |
| 2019-12-31Q4 FY2019 | 2020-02-26 | $1.05 | $4.15B | +59.1% | -62.3% | — | — |
| 2019-09-30Q3 FY2019 | 2019-11-05 | $0.71 | $12.40B | +1.4% | +14.9% | — | — |
| 2019-06-30Q2 FY2019 | 2019-08-06 | $0.98 | $11.76B | +63.3% | +12.4% | — | — |
| 2019-03-31Q1 FY2019 | 2019-05-08 | $1.07 | $10.82B | +311.5% | +7.8% | — | — |
| 2018-12-31Q4 FY2018 | 2019-02-27 | $0.66 | $11.00B | +283.3% | +5.4% | — | — |
| 2018-09-30Q3 FY2018 | 2018-11-06 | $0.70 | $10.79B | +3600.0% | +4.5% | — | — |
| 2018-06-30Q2 FY2018 | 2018-08-07 | $0.60 | $10.46B | -11.8% | +5.4% | — | — |
| 2018-03-31Q1 FY2018 | 2018-05-08 | $0.26 | $10.04B | -50.9% | +6.4% | — | — |
| 2017-12-31Q4 FY2017 | 2018-02-27 | $-0.36 | $10.43B | -89.5% | +3.1% | — | — |
| 2017-09-30Q3 FY2017 | 2017-11-07 | $-0.02 | $10.32B | -102.7% | -2.0% | — | — |
| 2017-06-30Q2 FY2017 | 2017-08-08 | $0.68 | $9.93B | — | — | — | — |
| 2017-03-31Q1 FY2017 | 2017-05-09 | $0.53 | $9.43B | — | — | — | — |
| 2016-12-31Q4 FY2016 | 2017-02-28 | $-0.19 | $10.12B | — | — | — | — |
| 2016-09-30Q3 FY2016 | 2016-11-07 | $0.74 | $10.54B | — | — | — | — |
Need MRK data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.